# A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

> **NCT01752075** · — · COMPLETED · sponsor: **Celgene** · enrollment: 100 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Revlimid

## Key facts

- **NCT ID:** NCT01752075
- **Lead sponsor:** Celgene
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2013-07-12
- **Final completion:** 2013-07-19
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752075, "A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01752075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*